Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹4,224 Cr revenue.
COGS 68.3%, employees 7.2%.
“EBITDA declined by 5% year on year at $2.51 crores vis a vis $2.65 crores in H1 FY25”
“We expect the requisite approvals to come in this quarter and business to commence twice from Q4 FY twenty twenty six.”
“Consolidated volumes for the quarter remained flat year on year and quarter on quarter while performance affected a high single digit decline.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 11.1%▲ | 7.6% |
| ROCE | 14.3%▲ | 10.9% |
| Net Margin | 5.5%▲ | 5.1% |
| EBITDA Margin | 9.8%▼ | 12.1% |
| Debt To Equity | 0.08x▼ | 0.20x |
| Rev Growth 3yr | 4.7%▼ | 5.9% |
| EPS Growth 3yr | 5.1%▲ | -9.4% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,079 Cr +20.2% | ₹4,224 Cr +11.3% | ₹3,794 Cr -14.6% | ₹4,445 Cr +20.6% | ₹3,686 Cr +32.4% | ₹2,784 Cr +7.2% | ₹2,596 Cr -6.0% | ₹2,763 Cr |
| Other Income | ₹30 Cr +14.6% | ₹26 Cr -27.2% | ₹35 Cr +260.0% | ₹10 Cr -21.3% | ₹13 Cr +15.2% | ₹11 Cr +83.4% | ₹6 Cr +26.5% | ₹5 Cr |
| Total Income | ₹5,108 Cr +20.2% | ₹4,249 Cr +11.0% | ₹3,830 Cr -14.0% | ₹4,455 Cr +20.5% | ₹3,698 Cr +32.3% | ₹2,795 Cr +7.4% | ₹2,602 Cr -6.0% | ₹2,768 Cr |
| COGS | ₹3,751 Cr +30.0% | ₹2,886 Cr +11.9% | ₹2,578 Cr -16.8% | ₹3,100 Cr +19.8% | ₹2,589 Cr +45.9% | ₹1,775 Cr +3.5% | ₹1,715 Cr -11.9% | ₹1,948 Cr |
| ₹4,745 Cr +22.6% | ₹3,869 Cr +12.0% | ₹3,454 Cr -13.3% | ₹3,982 Cr +18.2% | ₹3,369 Cr +39.1% | ₹2,423 Cr +4.7% | ₹2,313 Cr -7.1% | ₹2,491 Cr | |
| Profit Before Tax | ₹352 Cr -7.6% | ₹380 Cr +1.3% | ₹375 Cr -20.6% | ₹473 Cr +43.6% | ₹329 Cr -11.6% | ₹372 Cr +28.9% | ₹289 Cr +4.3% | ₹277 Cr |
| Exceptional Items | (₹12 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹71 Cr -6.3% | ₹76 Cr +2.1% | ₹74 Cr -19.5% | ₹92 Cr +38.2% | ₹67 Cr -5.2% | ₹70 Cr +20.1% | ₹58 Cr -32.0% | ₹86 Cr | |
| Net Profit | ₹281 Cr -7.9% | ₹305 Cr +1.1% | ₹301 Cr -20.9% | ₹381 Cr +45.0% | ₹263 Cr -13.0% | ₹302 Cr +31.1% | ₹230 Cr +20.6% | ₹191 Cr |
| Profit (Owners) | ₹281 Cr -7.9% | ₹305 Cr +1.1% | ₹301 Cr -20.9% | ₹381 Cr +45.0% | ₹263 Cr -13.0% | ₹302 Cr +31.1% | ₹230 Cr +20.6% | ₹191 Cr |
| Other Comprehensive Income | ₹48 Cr +136.5% | ₹20 Cr +114.9% | ₹9 Cr -82.8% | ₹55 Cr +125.4% | ₹24 Cr ↑ Recovery | (₹19 Cr) ↓ Decline | ₹33 Cr +82.2% | ₹18 Cr |
| EPS | ₹79.20 | ₹86.00 | ₹85.03 | ₹107.46 | ₹74.12 | ₹85.22 | ₹64.99 | ₹53.87 |
| Diluted Shares | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Galaxy Surfactants Limited has informed the Exchange about Transcript
Galaxy Surfactants Limited has informed the Exchange about Schedule of meet
Galaxy Surfactants Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Reg...
Galaxy Surfactants Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Galaxy Surfactants Limited has informed the Exchange about Transcript
Galaxy Surfactants Limited has informed the Exchange about Schedule of meet
Galaxy Surfactants Limited has informed the Exchange about Link of Recording
Galaxy Surfactants Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press release on the unaudited financial results for the quarter and nine months ended D...
Galaxy Surfactants Limited has informed the Exchange about Investor Presentation
Galaxy Surfactants Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Galaxy Surfactants Limited has informed the Exchange about Schedule of meet
Intimation of Change in Corporate Logo
Galaxy Surfactants Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Galaxy Surfactants Limited has informed the Exchange about Schedule of meet
Galaxy Surfactants Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015